CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Optimizing HRT: Emerging Lower-Dose Therapies CME
Chairperson: Rogerio A. Lobo, MD; Faculty: Maxine H. Dorin, MD; Michael Kleerekoper, MD, Face; Wulf H. Utian, MD, PhD
Disclosures

Release Date: September 4, 2001; Valid for credit through September 4, 2002

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity is based on transcripts and slides of presentations as delivered by the faculty at "Optimizing HRT: Emerging Lower-Dose Therapies" held in Chicago, Illinois on April 30, 2001.

Contents of This CME Activity
    New HRT Dosing Options For Menopausal Symptom Relief
    Rogerio A. Lobo, MD
    Introduction
    New HRT Dosing Options for Menopausal Symptom Relief
    Wulf H. Utian, MD, PhD
    Introduction to the Women's HOPE Study
    Women's HOPE Study: Vasomotor Symptoms
    Women's HOPE Study: Vaginal Atrophy
    Women's HOPE Study: Clinical Implications
    Providing Endometrial Protection With Improved Amenorrhea Rates: Clinical Implications of Lowering the HRT Dose
    Maxine H. Dorin, MD
    Introduction
    Women's HOPE Study: Hyperplasia
    Reasons for Discontinuation of HRT
    Women's HOPE Study: Bleeding
    Women's HOPE Study: Adverse Events
    Women's HOPE Study: Summary
    Women's HOPE Study: Clinical Implications
    Effects of Lowering HRT Doses on Lipids, Hemostatic Profile, and Carbohydrate Metabolism
    Rogerio A. Lobo, MD
    Introduction
    Women's HOPE Study: Substudy Measures and Population
    Women's HOPE Study: Lipids
    Women's HOPE Study: Carbohydrate Metabolism
    Women's HOPE Study: Hemostatic Profile
    Women's HOPE Study: Summary
    Women's HOPE Study: Clinical Implications
    Osteoporosis Prevention With Lower HRT Doses
    Michael Kleerekoper, MD, FACE
    Introduction
    Studies on Lower-Dose HRT and Bone Loss
    Women's HOPE Study: Bone Substudy
    Summary
    New HRT Dosing Options For Menopausal Symptom Relief - Summary
These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, the CME provider, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2001 Discovery International
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.